Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

James Bried

Orthopaedic Surgery Poway, CA Medical Doctor

NPI 1891809257 CMS profile 787187

15525 Pomerado Rd, Suite A-1, Poway, CA 92064

Open in the dashboard

General payments

$2,990

61 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, James Bried of Poway, CA is reported in the CMS Open Payments database as having received $2,990 across 61 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 46th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $265 12
2024 General $681 12
2023 General $67 4
2022 General $1,269 3
2021 General $81 4
2020 General $324 14
2019 General $303 12

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • James Bried
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to James Bried were reported at $265. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year James Bried Orthopaedic Surgery median Middle half National median
2019 $303 $644 $140–$2,844 $163
2020 $324 $312 $75–$1,860 $114
2021 $81 $520 $117–$2,495 $132
2022 $1,269 $598 $128–$2,731 $149
2023 $67 $461 $128–$2,264 $160
2024 $681 $497 $134–$2,475 $164
2025 $265 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. ImpactOrtho, Inc. $1,200 1 payment
  2. Stryker Corporation $598 14 payments
  3. DePuy Synthes Sales Inc. $416 14 payments
  4. Horizon Therapeutics plc $241 17 payments
  5. Smith+Nephew, Inc. $173 5 payments
  6. Becton, Dickinson and Company $155 1 payment
  7. Sanofi-Aventis U.S. LLC $50 2 payments
  8. Flexion Therapeutics, Inc. $45 1 payment
  9. Wright Medical Technology, Inc. $24 1 payment
  10. Integra LifeSciences Corporation $21 1 payment
  11. Other $66 4 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $1,751 59 payments
  2. Education $1,200 1 payment
  3. Travel and Lodging $39 1 payment
Products named General payments · program years 2019–2025
  1. AEQUALIS PERFORM $266 4 payments
  2. ORTHOVISC $264 10 payments
  3. PENNSAID $214 15 payments
  4. VARIAX $114 1 payment
  5. STAR $114 1 payment
  6. VA-LCP PLATES & SCREWS $102 1 payment
  7. TFN ADVANCED $102 1 payment
  8. BME NITINOL CONTINUOUS COMPRESSION IMPLANTS $102 1 payment
  9. AEQUALIS PERFORM REVERSED $63 3 payments
  10. ANTHOLOGY $57 1 payment
  11. Other $765 34 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 6 drugs

Part D claims

295

Median for Orthopedic Surgery: 203

Drug cost

$3,221

Median for Orthopedic Surgery: $1,433

Branded share of claims

61%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 130 $1,368
Diclofenac Sodium Generic 61 $916
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 50 $536
Tramadol Hcl Generic 23 $147
Celecoxib Generic 11 $128
Ibuprofen Generic 20 $126

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 76 billing codes

Paid by Medicare

$259,415

Of which drugs: $9,690

Medicare patients

586

Average age 76

Services billed

14,866

303 women, 283 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 67%
Ischemic heart disease 20%
Osteoporosis 20%
Depression 19%
Diabetes 18%
Atrial fibrillation 17%
Chronic kidney disease 17%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, methylprednisolone acetate, 1 mg J1010 Office 168 12,334 $1,246
Injection, methylprednisolone acetate, 40 mg J1030 Office 99 237 $1,027

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

61 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record